Workflow
复尔凯肠内营养输注系统
icon
Search documents
达能纽迪希亚无锡生产基地扩建项目正式封顶
Bei Jing Shang Bao· 2025-10-13 11:34
Core Insights - Danone Nutricia's Wuxi factory expansion project has officially topped out, aiming to build multiple fully automated sterilization production lines to enhance the production capacity of enteral nutrition suspensions [1] Company Overview - Danone Nutricia Pharmaceutical (Wuxi) Co., Ltd. was established in 2000 and has developed a comprehensive product system covering enteral nutrition products and supporting medical devices in the Chinese market [1] - The Wuxi factory produces enteral nutrition formulations such as EnfaCare and Peptamen, as well as the Nutricia enteral nutrition infusion system, which serves various clinical fields including oncology, stroke, allergies, digestive system diseases, and elderly nutrition [1] Market Position - China is Danone's second-largest global market and a crucial driver for future growth [1] - The expansion of advanced medical nutrition production capacity in Wuxi will enable the company to provide more efficient and precise personalized medical nutrition solutions to consumers [1]
达能纽迪希亚无锡生产基地扩建升级
Jing Ji Guan Cha Wang· 2025-10-13 09:39
Core Insights - Danone Nutricia Pharmaceutical (Wuxi) Co., Ltd. has officially completed the topping-out of its factory expansion project, which aims to enhance the production capacity of enteral nutrition suspensions through the establishment of multiple fully automated sterilization production lines [1] Group 1: Company Development - The expansion project signifies that Danone Nutricia's medical nutrition business in China is entering a phase of accelerated growth [1] - Danone has outlined a mid-term development strategy for 2025-2028 that emphasizes the acceleration of its medical nutrition business [1] Group 2: Product and Market Focus - Danone Nutricia Pharmaceutical (Wuxi) Co., Ltd. was established in 2000 and has developed a comprehensive product system covering enteral nutrition products and supporting medical devices in the Chinese market [1] - The Wuxi factory produces enteral nutrition formulations such as Nengquan and Baipuli, as well as the Fulekai enteral nutrition infusion system, which serve various clinical fields including oncology, stroke, allergies, gastrointestinal diseases, and elderly nutrition [1] - In 2018, the Wuxi factory initiated a special medical nutrition food project and launched the Nengquanli Yijia special medical purpose full-nutrition formula food in 2023, targeting individuals over 10 years old with eating restrictions, digestive absorption disorders, or metabolic disorders [1]